Advertisement

European Radiology

, Volume 16, Issue 6, pp 1316–1322 | Cite as

Superficial femoral artery: current treatment options

  • Gunnar TepeEmail author
  • Jörg Schmehl
  • Stephan Heller
  • Benjamin Wiesinger
  • Claus D. Claussen
  • Stephan H. Duda
Vascular-Interventional

Abstract

Treatment of the superficial femoral artery (SFA) has been among the least effective of all endovascular procedures in terms of long-term patency. The relatively small vessel lumen, in conjunction with a high plaque burden, slow flow, and a high frequency of primary occlusions, contributes to a considerable rate of acute technical failures. Because of these technical limitations a much effort has been made during the past years. This manuscript should summarize the hopes and limitations of different approaches such as brachytherapy, cutting balloons, stents and stent grafts, drug-eluting stents, and drug-coated balloons.

Keywords

Peripheral artery Restenosis Stent Balloon angioplasty Intervention 

References

  1. 1.
    Transatlantic Intersociety Consensus Group (2000) Management of peripheral arterial disease (PAD). Transatlantic Inter-Society Consensus (TASC). Eur J Vasc Endovasc Surg 19 [Suppl A]:Si–Sxxviii, S1–S250Google Scholar
  2. 2.
    Cheng SW, Ting AC, Wong J (2001) Endovascular stenting of superficial femoral artery stenosis and occlusions: results and risk factor analysis. Cardiovasc Surg 9:133–140CrossRefPubMedGoogle Scholar
  3. 3.
    Minar E, Ahmadi RA, Ehringer H, Marosi L, Czembirek H, Konecny U (1986) Percutaneous transluminal angioplasty (PTA) in peripheral arterial occlusive disease of the lower extremities (in German). Wien Klin Wochenschr 98:33–40PubMedGoogle Scholar
  4. 4.
    Duda SH, Poerner TC, Wiesinger B, Rundback JH, Tepe G, Wiskirchen J, Haase, KK (2003) Drug-eluting stents: potential applications for peripheral arterial occlusive disease. J Vasc Interv Radiol 14:291–301PubMedGoogle Scholar
  5. 5.
    Duda SH, Bosiers M, Lammer J, Scheinert D, Zeller T, Tielbeek A, Anderson J, Wiesinger B, Tepe G, Lansky A, Mudde C, Tielemans H, Beregi JP (2005) Sirolimus-eluting versus bare nitinol stent for obstructive superficial femoral artery disease: the SIROCCO II trial. J Vasc Interv Radiol 16:331–338PubMedGoogle Scholar
  6. 6.
    Grenacher L, Saam T, Geier A, Muller-Hulsbeck S, Cejna M, Kauffmann GW, Richter GM (2004) PTA versus Palmaz stent placement in femoropopliteal artery stenoses: results of a multicenter prospective randomized study (REFSA) (in German). Rofo Fortschr Geb Rontgenstr Neuen BildgebVerfahr 176:1302–1310CrossRefGoogle Scholar
  7. 7.
    Herzog C, Grebe C, Mahnken A, Balzer JO, Mack MG, Zangos S, Ackermann H, Schaller S, Seifert T, Ohnesorge B, Vogl TJ (2005) Peripheral artery stent visualization and in-stent stenosis analysis in 16-row computed tomography: an in-vitro evaluation. Eur Radiol 15:2276–2283PubMedCrossRefGoogle Scholar
  8. 8.
    Mewissen MW (2004) Self-expanding nitinol stents in the femoropopliteal segment: technique and mid-term results. Tech Vasc Interv Radiol 7:2–5CrossRefPubMedGoogle Scholar
  9. 9.
    Vogel JH (1994) Stents: a time for clinical judgment. J Am Coll Cardiol 24:1213PubMedCrossRefGoogle Scholar
  10. 10.
    Duda SH, Pusich B, Richter G, Landwehr P, Oliva VL, Tielbeek A, Wiesinger B, Hak JB, Tielemans H, Ziemer G, Cristea E, Lansky A, Beregi JP (2002) Sirolimus-eluting stents for the treatment of obstructive superficial femoral artery disease: six-month results. Circulation 106:1505–1509CrossRefPubMedGoogle Scholar
  11. 11.
    Tepe G, Schmehl J, Claussen CD, Ernemann U, Pereira P, Duda SH (2005) Drug coated stents for carotid intervention. J Cardiovasc Surg (Torino) 46:249–259Google Scholar
  12. 12.
    Toutouzas K, Di Mario C, Falotico R, Takagi T, Stankovic G, Albiero R, Corvaja N, Colombo A (2002) Sirolimus-eluting stents: a review of experimental and clinical findings. Z Kardiol 91 [Suppl 3]:49–57CrossRefPubMedGoogle Scholar
  13. 13.
    Scheinert D, Scheinert S, Sax J, Piorkowski C, Braunlich S, Ulrich M, Biamino G, Schmidt A (2005) Prevalence and clinical impact of stent fractures after femoropopliteal stenting. J Am Coll Cardiol 45:312–315CrossRefPubMedGoogle Scholar
  14. 14.
    Ahmadi R, Schillinger M, Maca T, Minar E (2002) Femoropopliteal arteries: immediate and long-term results with a Dacron-covered stent graft. Radiology 223:345–350PubMedCrossRefGoogle Scholar
  15. 15.
    Bray PJ, Robson WJ, Bray AE (2003) Percutaneous treatment of long superficial femoral artery occlusive disease: efficacy of the Hemobahn stent graft. J Endovasc Ther 10:619–628CrossRefPubMedGoogle Scholar
  16. 16.
    Saxon RR, Coffman JM, Gooding JM, Natuzzi E, Ponec DJ (2003) Long-term results of ePTFE stent graft versus angioplasty in the femoropopliteal artery: single center experience from a prospective, randomized trial. J Vasc Interv Radiol 14:303–311PubMedGoogle Scholar
  17. 17.
    Deutschmann HA, Schedlbauer P, Berczi V, Portugaller H, Tauss J, Hausegger KA (2001) Placement of Hemobahn stent grafts in femoropopliteal arteries: early experience and midterm results in 18 patients. J Vasc Interv Radiol 12:943–950PubMedCrossRefGoogle Scholar
  18. 18.
    Grassl ED, Bischof JC (2005) In vitro model systems for evaluation of smooth muscle cell response to cryoplasty. Cryobiology 50:162–173CrossRefPubMedGoogle Scholar
  19. 19.
    Fava M, Loyola S, Polydorou A, Papapavlou P, Polydorou A, Mendiz O, Joye JD (2004) Cryoplasty for femoropopliteal arterial disease: late angiographic results of initial human experience. J Vasc Interv Radiol 15:1239–1243PubMedGoogle Scholar
  20. 20.
    Ansel GM, Sample NS, Botti IC Jr, Tracy AJ, Silver MJ, Marshall BJ, George BS (2004) Cutting balloon angioplasty of the popliteal and infrapopliteal vessels for symptomatic limb ischemia. Catheter Cardiovasc Interv 61:1–4CrossRefPubMedGoogle Scholar
  21. 21.
    Cejna M (2005) Review on principles and background of use in peripheral arteries. Cardiovasc Intervent Radiol 28:400–408CrossRefPubMedGoogle Scholar
  22. 22.
    Engelke C, Sandhu C, Morgan RA, Belli AM (2002) Using 6-mm cutting balloon angioplasty in patients with resistant peripheral artery stenosis: preliminary results. AJR Am J Roentgenol 179:619–623PubMedGoogle Scholar
  23. 23.
    Böttcher HD, Schopohl B, Liermann D, Kollath J, Adamietz IA (1994) Endovascular irradiation—a new method to avoid recurrent stenosis after stent implantation in peripheral arteries: technique and preliminary results. Int J Radiat Oncol Biol Phys 29:183–186PubMedGoogle Scholar
  24. 24.
    Liermann D, Böttcher HD, Kollath J, Schopohl B, Strassmann G, Strecker EP, Breddin KH (1994) Prophylactic endovascular radiotherapy to prevent intimal hyperplasia after stent implantation in femoropopliteal arteries. Cardiovasc Intervent Radiol 17:12–16CrossRefPubMedGoogle Scholar
  25. 25.
    Liermann DD, Bauernsachs R, Schopohl B, Bottcher HD (1997) Five year follow-up after brachytherapy for restenosis in peripheral arteries. Semin Interv Cardiol 2:133–137PubMedGoogle Scholar
  26. 26.
    Pokrajac B, Pötter R, Maca T, Fellner C, Mittlböck M, Ahmadi R, Seitz W, Minar E (2000) Intraarterial (192)Ir high-dose-rate brachytherapy for prophylaxis of restenosis after femoropopliteal percutaneous transluminal angioplasty: the prospective randomized Vienna-2 trial radiotherapy parameters and risk factors analysis. Int J Radiat Oncol Biol Phys 48:923–931PubMedCrossRefGoogle Scholar
  27. 27.
    Pokrajac B, Potter R, Wolfram RM, Budinsky AC, Kirisits C, Lileg B, Mendel H, Sabeti S, Schmid R, Minar E (2005) Endovascular brachytherapy prevents restenosis after femoropopliteal angioplasty: results of the Vienna-3 randomised multicenter study. Radiother Oncol 74:3–9CrossRefPubMedGoogle Scholar
  28. 28.
    Wolfram RM, Budinsky AC, Pokrajac B, Potter R, Minar E (2005) Vascular brachytherapy with 192Ir after femoropopliteal stent implantation in high-risk patients: twelve-month follow-up results from the Vienna-5 trial. Radiology 236:343–351PubMedCrossRefGoogle Scholar
  29. 29.
    Wolfram RM, Budinsky AC, Pokrajac B, Potter R, Minar E (2005) Endovascular brachytherapy: restenosis in de novo versus recurrent lesions of the femoropopliteal artery—the Vienna experience. Radiology 236:338–342PubMedCrossRefGoogle Scholar
  30. 30.
    Scheller B, Speck U, Abramjuk C, Bernhardt U, Bohm M, Nickenig G (2004) Paclitaxel balloon coating, a novel method for prevention and therapy of restenosis. Circulation 110:810–814CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag 2006

Authors and Affiliations

  • Gunnar Tepe
    • 1
    Email author
  • Jörg Schmehl
    • 1
  • Stephan Heller
    • 1
  • Benjamin Wiesinger
    • 1
  • Claus D. Claussen
    • 1
  • Stephan H. Duda
    • 2
  1. 1.Department of Diagnostic RadiologyUniversity of TuebingenTuebingenGermany
  2. 2.Department of Diagnostic and International RadiologyThe Jewish HospitalBerlinGermany

Personalised recommendations